Egypt vs Guinea-Bissau: The number of people with susceptibility test result for rifampicin
Egypt
89
in 2021
Guinea-Bissau
89.04
in 2021
Egypt rank
71st
Guinea-Bissau rank
70th
The number of people with susceptibility test result for rifampicin over time
- Egypt
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 89.04 against 89 in Egypt, a difference of 0.04.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Egypt ahead.
Egypt ranks 71st and Guinea-Bissau ranks 70th of 146 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Egypt | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.01 | 1.23 | 64.78 | Egypt |
| 2020s | 87.01 | 73.23 | 13.78 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Egypt or Guinea-Bissau?
- Guinea-Bissau, at 89.04 against 89 in Egypt as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Egypt and Guinea-Bissau?
- 0.04, with Guinea-Bissau ahead.
- How many years of comparable data are there for Egypt and Guinea-Bissau?
- 5 years are reported by both, from 2017 to 2021.
- How do Egypt and Guinea-Bissau rank globally for the number of people with susceptibility test result for rifampicin?
- Egypt ranks 71st and Guinea-Bissau ranks 70th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.